Faeth Therapeutics
Develops PIKTOR, an oral cancer regimen designed to block multiple PAM-pathway nodes.
$33.84
After-hours close+0.16 (+0.48%)
At close$33.68(−0.18%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.66 | — | — |
| Aug 2026 | −$2.64 | −$2.84 | −7.6% |
| May 2026 | −$0.62 | −$131.45 | −21,101.6% |
| Mar 2026 | −$4.81 | −$3.74 | +22.2% |
| Nov 2025 | −$4.11 | −$3.62 | +11.9% |
The latest year is open to everyone — the 23 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | −$0.66 | — | — | — | — | — |
| Aug 4, 2026 | −$2.64 | −$2.84 | −7.6% | — | — | — |
| May 15, 2026 | −$0.62 | −$131.45 | −21,101.6% | — | — | — |
| Mar 30, 2026 | −$4.81 | −$3.74 | +22.2% | — | — | — |
| Nov 14, 2025 | −$4.11 | −$3.62 | +11.9% | — | −$4.9M | — |
The latest year is open to everyone — the 23 quarters behind it read with an account. Sign in | ||||||
| Aug 5, 2025 | ||||||
| May 6, 2025 | ||||||
| Mar 28, 2025 | ||||||
| Nov 14, 2024 | ||||||
| Aug 6, 2024 | ||||||
| May 9, 2024 | ||||||
| Feb 28, 2024 | ||||||
| Nov 7, 2023 | ||||||
| Aug 3, 2023 | ||||||
| May 9, 2023 | ||||||
| Mar 23, 2023 | ||||||
| Nov 8, 2022 | ||||||
| Aug 9, 2022 | ||||||
| May 10, 2022 | ||||||
| Mar 10, 2022 | ||||||
| Nov 9, 2021 | ||||||
| Aug 4, 2021 | ||||||
| May 12, 2021 | ||||||
| Mar 25, 2021 | ||||||
| Sep 30, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Mar 31, 2020 | ||||||
| Dec 31, 2019 | ||||||